Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fontaine, G
Right arrow Articles by Rougier, I
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fontaine, G
Right arrow Articles by Rougier, I

Chest, Vol 95, 785-797, Copyright © 1989 by American College of Chest Physicians

ARTICLES

Clinical experience with fulguration and antiarrhythmic therapy for the treatment of ventricular tachycardia. Long-term follow-up of 43 patients

G Fontaine, JL Tonet, R Frank and I Rougier
Service de Rythmologie, Hopital Jean Rostand, Ivry, France.

Forty-three patients (mean age, 45 +/- 18 years) with drug-refractory VT of varied etiologies, including 15 cases occurring after chronic myocardial infarction, underwent fulguration procedures. With a mean follow-up of 29 +/- 12 months (range, 9 to 55 months), after one to four sessions, VT had been controlled without a need for antiarrhythmic drugs in 22 (56 percent) of the 39 patients surviving the perioperative period and was controlled in 17 patients (44 percent) with the help of drugs. No malignant arrhythmias were observed following fulguration. There were five early deaths, four deaths related to the procedure, and eight late deaths, but no death was thought to be related to the endocardial shock itself. Thus, fulguration appears to be a valuable adjunct to the treatment of drug-resistant VT.


This article has been cited by other articles:


Home page
 CirculationHome page
O. Kinoshita, G. Fontaine, F. Rosas, J. Elias, T. Iwa, J. Tonet, G. Lascault, and R. Frank
Time- and Frequency-Domain Analyses of the Signal-Averaged ECG in Patients With Arrhythmogenic Right Ventricular Dysplasia
Circulation, February 1, 1995; 91(3): 715 - 721.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
L. L. Mickleborough, S. Mizuno, A. Usui, G. Wilson, D. McComb, and G. Gray
Balloon electric shock ablation--A surgical technique for treatment of ventricular tachycardia: Influence of endocardial scar on depth of ablation achieved
J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 855 - 861.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Chest Physicians.